Preventive use of ascorbic acid for postoperative atrial fibrillation

Preventive use of ascorbic acid for postoperative atrial fibrillation in patients undergoing coronary artery bypass graft surgery

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016090228945N2

Enrollment

330

Registered

2017-05-05

Start date

2016-12-05

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiac arrhythmia. Other postprocedural disorders of circulatory system, not elsewhere classified

Interventions

Intervention 1: Intervention group: 165 patients receive vitamin C. Intervention 2: Control group: 165 patients receive placebo.

Treatment - Drugs

Placebo

Intervention group: 165 patients receive vitamin C

Control group: 165 patients receive placebo

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: inclusion: no arrhythmia, coronary artery bypass alone, normal sinus rhythm preoperatively exclusion criteria: emergency operation, antiarryhthmic drug postoperatively

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Atrial fibrillation. Timepoint: 3 days in ICU then in ward. Method of measurement: ECG.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir Mirmohammad Sadeghi

Islamic Azad University, Najafabad branch

am_sadeghi@med.mui.ac.ir+98 913 108 5664

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026